Pedunculoside targets P2X7R to protect against myocarditis by regulating the NLRP3/PIP2/MAPK signaling pathway

Youqiong Zhuo1,2, Jia He1,3, Qin-Qin Wang1,3

  • 1College of Pharmacy, Guangxi University of Chinese Medicine, Nanning, China.

PubMed
Abstract

Insights

Pedunculoside (PE) demonstrates significant anti-myocarditis activity by protecting heart cells and improving cardiac function. It acts by inhibiting key inflammatory pathways, suggesting potential for myocarditis treatment.

Area of Science:

  • Cardiovascular Biology
  • Pharmacology
  • Immunology

Background:

  • Myocarditis involves myocardial inflammation, cell necrosis, and inflammatory infiltration.
  • Pedunculoside (PE) is known for anti-inflammatory properties but its role in myocarditis is unstudied.

Purpose of the Study:

  • To evaluate the cardioprotective effects of Pedunculoside (PE) in myocarditis.
  • To elucidate the underlying mechanisms of PE's action in myocarditis.

Main Methods:

  • In vitro: LPS + ATP-induced cardiomyocyte injury model.
  • In vivo: LPS-induced rat myocarditis model.
  • Assessed cell death, ROS, Ca2+ levels, MMP, cardiac function, and molecular pathways.

Main Results:

  • PE inhibited H9c2 cell death, reduced oxidative stress, calcium overload, and mitochondrial membrane potential loss.
  • PE improved cardiac function in a rat model of myocarditis.
  • PE suppressed NLRP3 inflammasome, PIP2, and MAPK signaling pathways via P2X7R interaction.

Conclusions:

  • Pedunculoside (PE) exhibits significant anti-myocarditis effects.
  • PE acts by interacting with P2X7R and inhibiting NLRP3, PIP2, and MAPK pathways.
  • PE shows promise as a therapeutic agent for clinical myocarditis treatment.